C8..
CANCELLED SEC. 8 (6-YR)
07/31/2026
Back to search
Official data from USPTO
PHARMATEK SD
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (6-YR)Type: WordOffice: United States
Quick snapshot
PHARMATEK SD
ST13
US500000088039119Class
42
Filing
88039119
Registration
5964622
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (6-YR)
Case type
Application and registration
Recorded events
28
Latest update
07/31/2026
Trademark type
Word
Nice classes
42
Filing date
07/16/2018
Registration date
01/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/31/2026
Last transaction
07/31/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
First use anywhere
2017-02-00
First use in commerce
2017-02-00
Drawing code
4
Owner type
03
Owner location
Somerset, NJ, US
Examiner
YONTEF, DAVID ERIC
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CATALENT PHARMA SOLUTIONS, INC.
Representatives
VANESSA A. IGNACIO, ESQ. LOWENSTEIN SANDLER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; pharmaceutical products development; research and development of technology in the field of pharmaceutical spray drying
Publications
History of USPTO decisions and trademark events.
28 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/21/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/05/2019
PUBO
PUBLISHED FOR OPPOSITION
11/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/16/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/30/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
09/30/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/30/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
09/30/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/30/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/22/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/22/2019
GNFR
FINAL REFUSAL E-MAILED
02/22/2019
CNFR
FINAL REFUSAL WRITTEN
02/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/25/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/30/2018
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/30/2018
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
10/30/2018
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
10/30/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/30/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/29/2018
DOCK
ASSIGNED TO EXAMINER
10/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2018
NWAP
NEW APPLICATION ENTERED
07/19/2018
Continuous trademark protection
Get notified about every new filing that threatens PHARMATEK SD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.